AstraZeneca PLC Total Liabilities

Latest as of June 2026: GBX65.80 Billion GBX ≈ $8.01 Million USD

AstraZeneca PLC total liabilities. Based on the latest financial reports, AstraZeneca PLC (AZN) has total liabilities worth GBX65.80 Billion GBX (≈ $8.01 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of AstraZeneca PLC to evaluate the company's liquid asset resilience ratio.

Total Liabilities of AstraZeneca PLC (1990–2025)

Total liabilities of AstraZeneca PLC from 1990 to 2025. This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of AstraZeneca PLC to see how much of total assets are deployed in long-term investments.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Beijing Sinnet Technology Co Ltd SHE:300383	China	CN¥8.17 Billion
Almirall S.A. MC:ALM	Spain	€882.40 Million
Ansell Limited F:PD1A	Germany	€1.34 Billion
CLARIANT ADR 1/SF 4 F:CLRS	Germany	€3.69 Billion
ZIM Integrated Shipping Services Ltd. F:2SV	Germany	€6.98 Billion
NBT Bancorp Inc NASDAQ:NBTB	USA	$14.27 Billion
Flat Glass Group Co. Ltd SHG:601865	China	CN¥19.62 Billion
People.Cn Co Ltd SHG:603000	China	CN¥1.52 Billion

Liability Composition Analysis (1990–2025)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AZN asset base.

Liquidity & Leverage Metrics

AstraZeneca PLC Total Liabilities Ratios Explained

AstraZeneca PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.30	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.57	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (1990–2025)

The table below shows the annual total liabilities of AstraZeneca PLC from 1990 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX65.36 Billion ≈ $7.95 Million	+3.47%
2024-12-31	GBX63.16 Billion ≈ $7.69 Million	+1.95%
2023-12-31	GBX61.95 Billion ≈ $7.54 Million	+4.25%
2022-12-31	GBX59.42 Billion ≈ $7.23 Million	-10.07%
2021-12-31	GBX66.08 Billion ≈ $8.04 Million	+29.33%
2020-12-31	GBX51.09 Billion ≈ $6.22 Million	+9.21%
2019-12-31	GBX46.78 Billion ≈ $5.69 Million	+0.37%
2018-12-31	GBX46.61 Billion ≈ $5.67 Million	-0.22%
2017-12-31	GBX46.71 Billion ≈ $5.68 Million	+1.86%
2016-12-31	GBX45.86 Billion ≈ $5.58 Million	+10.19%
2015-12-31	GBX41.62 Billion ≈ $5.06 Million	+6.84%
2014-12-31	GBX38.95 Billion ≈ $4.74 Million	+19.31%
2013-12-31	GBX32.65 Billion ≈ $3.97 Million	+10.36%
2012-12-31	GBX29.58 Billion ≈ $3.60 Million	+0.76%
2011-12-31	GBX29.36 Billion ≈ $3.57 Million	-10.27%
2010-12-31	GBX32.72 Billion ≈ $3.98 Million	-4.05%
2009-12-31	GBX34.10 Billion ≈ $4.15 Million	+10.39%
2008-12-31	GBX30.89 Billion ≈ $3.76 Million	-6.51%
2007-12-31	GBX33.04 Billion ≈ $4.02 Million	+127.62%
2006-12-31	GBX14.52 Billion ≈ $1.77 Million	+30.20%
2005-12-31	GBX11.15 Billion ≈ $1.36 Million	-0.05%
2004-12-31	GBX11.15 Billion ≈ $1.36 Million	+8.13%
2003-12-31	GBX10.32 Billion ≈ $1.26 Million	-0.38%
2002-12-31	GBX10.36 Billion ≈ $1.26 Million	+16.78%
2001-12-31	GBX8.87 Billion ≈ $1.08 Million	-0.34%
2000-12-31	GBX8.90 Billion ≈ $1.08 Million	-6.04%
1999-12-31	GBX9.47 Billion ≈ $1.15 Million	+26.33%
1998-12-31	GBX7.50 Billion ≈ $912.05K	+60.91%
1997-12-31	GBX4.66 Billion ≈ $566.80K	-4.95%
1996-12-31	GBX4.90 Billion ≈ $596.33K	+1.40%
1995-12-31	GBX4.83 Billion ≈ $588.09K	+5.23%
1994-12-31	GBX4.59 Billion ≈ $558.87K	-9.94%
1993-12-31	GBX5.10 Billion ≈ $620.56K	-15.25%
1992-12-31	GBX6.02 Billion ≈ $732.24K	+10.52%
1991-12-31	GBX5.45 Billion ≈ $662.52K	+0.49%
1990-12-31	GBX5.42 Billion ≈ $659.26K	--

About AstraZeneca PLC

LSE:AZN UK Drug Manufacturers - General

Market Cap

$2.63 Billion

GBX21.60 Trillion GBX

Market Cap Rank

#5119 Global

#13 in UK

Share Price

GBX13930.00

Change (1 day)

-0.80%

52-Week Range

GBX11460.00 - GBX15542.00

All Time High

GBX15542.00